Alkor Bio Group's Laboratory of Allergology transferred to the production 27 new allergens, including 8 drug allergens at the first half of September. Thus, today Alkor Bio Group produces 511 positions. In spite of the line of drug allergens has started recently, now it includes 46 positions.

Among Alkor Bio Group's new innovative products there are: Doxycycline, Ambroxol, Bromhexine, Atropinum, Bacampicillin, Cobalamin (Vitamin B12), Ascorbic acid (Vitamin C) and Azithromycin.

Besides the drug allergens this time the Laboratory of Allergology has also developed food allergens: haddock, lecithin, cheese Maasdam, pike, veal, horse-flesh, quail meat, blackberry, bilberry, papaya, passion fruit, halibut, sardine; launched several allergens from the group of mold and yeast fungi (Phoma betae, Epidermophyton floccosum, Aspergillus flavus); completed the lines of pollen allergens (date palm Phoenix dactylifera) and epithelial allergens (gerbil epithelium). Also the new allergen component was developed - recombinant allergen of apple rMal d 1 Apple.